Trevor Nicholls has been Chief Executive Officer of CABI since 2005. He is also a non-executive director of three biotech companies – Avacta Group plc, Conidia Biosciences Ltd and Retroscreen Virology Group plc.
Under Trevor’s leadership, CABI has defined its mission as the strengthening of global capacity to solve problems in agriculture and the environment. The organisation has developed a strategic focus on providing knowledge to enable poor rural farmers in the developing world to grow more, raise quality and increase income. This is achieved through activities in scientific Publishing and International Development. Whilst Publishing provides a wide range of information encompassing human, animal, plant and environmental sciences, International Development focusses on the prevention and management of plant pests, diseases and invasive species. Leveraging the strengths and capabilities of both core businesses, CABI is leading Plantwise, a global initiative to increase global food security by reducing losses to pests and diseases.
Operationally, CABI has developed a stronger focus on providing objective science-based advice to its member countries, donors and customers, delivered through embedded systems of project management and financial control. CABI delivers its projects in close partnership with national institutions and NGOs in all the countries where it works and has established a very successful joint lab with CAAS in China.
As a result, CABI has secured significant funding from key donors including the Bill and Melinda Gates Foundation, UK (DFID and DEFRA), the Swiss Development Cooperation agency, CAAS, Netherlands (DGIS), ACIAR, EU DEVCO, Common Fund for Commodities, Global Environment Facility, USDA and USAID. It continues to operate as a financially self-sustaining, not-for-profit inter-governmental organisation, constantly looking to improve its performance in mainstreaming gender and measuring the outcomes and impacts of its work.
Previously, Trevor’s career covered experience of building international businesses in the genomics and life science industries serving major pharmaceutical, biotech and academic clients. He has broad experience of initiating change and restructuring organisations, ranging from start-ups to FTSE 100/Nasdaq quoted companies. Trevor holds a BA and D.Phil in Biochemistry from the University of York and Diploma qualifications in Marketing (CIM) and Company Directorship (IoD).